Coverage
-
October 30, 2013
The reorganized K-V Pharmaceutical Co. on Tuesday reached a $5 million settlement with a group of senior secured lenders who had sued to obtain $34.7 million in additional interest on the debt they held.
11 other articles on this case.
View all »